Meeting
2016 Genitourinary Cancers Symposium
Effects of interruptions of radiotherapy on outcomes of patients with prostate cancer.
Authors
Yanqun Dong
Fox Chase Cancer Center, Philadelphia, PA
Yanqun Dong , Tianyu Li , Thomas M. Churilla , Rosalia Viterbo , Mark L. Sobczak , Marc C. Smaldone , David Y. T. Chen , Robert G. Uzzo , Mark Hallman , Eric M. Horwitz
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer,Prostate Cancer
Sub Track
Prostate Cancer - Localized Disease
Citation
J Clin Oncol 34, 2016 (suppl 2S; abstr 37)
DOI
10.1200/jco.2016.34.2_suppl.37
Abstract #
37
Poster Bd #
B19
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Sexual function after primary external beam radiation therapy (EBRT) for prostate cancer in a large cohort of men with long-term follow-up.
First Author: Domenique Escobar
Poster
2023 ASCO Genitourinary Cancers Symposium
Pelvic clinical node-positive prostate cancer: Impact of radiotherapy and nodal disease burden.
First Author: Tony Felefly
Poster
2020 Genitourinary Cancers Symposium
18-year prostate cancer-specific mortality after prostatectomy, brachytherapy, external beam radiation therapy, hormonal therapy, or monitoring for localized prostate cancer.
First Author: Annika Herlemann
Poster
2020 Genitourinary Cancers Symposium
Adjuvant docetaxel for high-risk localized prostate cancer: Update of NRG Oncology/RTOG 0521.
First Author: Howard M. Sandler